FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke
The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability ...
ADVERTISEMENT
Tag: Dr. Clay Johnston
ADVERTISEMENT
Popular Last 24h
-
Ampersand wins £22m five-year contract at London Zoo
-
Who Is the Owner of QI Company? A Look at the QI Group’s Leadership Shaping Its Future
-
Patricia White Appointed as a Class C Director to the New York Fed Board of Directors
-
The pharmaceutical industry, grappling with new government limits on drug prices
-
Magical Night: Unique Hotels in Scandinavia
-
Official presidential portraits: two very different states of mind
-
The great global redistributor we never hear about: money sent or brought back by migrants
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
